CRPHAGE

Live / Registered — Registered (as of 11 Jan 2022)

What this means for you

Registered since 11 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
88171376
Registration number
6615709
Mark type
Stylized text
Filed
26 Oct 2018
Published for opposition
19 Mar 2019
Registered
11 Jan 2022
Attorney of record
Chelsea E. Carbone

Goods and services

  • Class 042 — Scientific and technological services: Pharmaceutical research and development; research and development in pharmacology for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders; medical and scientific research; pharmaceutical research in the field of engineered bacteriophage; pharmaceutical research using engineered therapeutics for use in antibacterial drug development; pharmaceutical research, namely, research relating to engineered bacteriophage platforms for improving pharmacological properties; pharmaceutical research, namely, research relating to engineered bacteriophages for use in connection with a wide variety of therapeutic agents

Owner

Prosecution history

  • 11 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
  • 08 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 07 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 20 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 19 Nov 2021 — STATEMENT OF USE PROCESSING COMPLETE
  • 12 Nov 2021 — USE AMENDMENT FILED
  • 19 Nov 2021 — SOU EXTENSION 5 GRANTED
  • 12 Nov 2021 — SOU EXTENSION 5 FILED
  • 19 Nov 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 12 Nov 2021 — SOU TEAS EXTENSION RECEIVED
  • 12 Nov 2021 — TEAS STATEMENT OF USE RECEIVED
  • 12 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 10 May 2021 — SOU EXTENSION 4 GRANTED
  • 10 May 2021 — SOU EXTENSION 4 FILED
  • 10 May 2021 — SOU TEAS EXTENSION RECEIVED

View this trademark record on Marksy